Faisal Khurshid Analyst Performance

Faisal A. Khurshid is a Senior Research Analyst at Leerink Partners leading our Emerging Immunology sector. Prior to joining the firm in 2021, Faisal worked as a consultant to several biopharma companies, with a focus on oncology and rare diseases. He started his career at ClearView Healthcare Partners, where he focused primarily on new product planning and product launch strategies. Subsequently, he joined Axiom Healthcare Strategies and led business development efforts as well as projects focused on emerging therapeutics and pipeline strategy in oncology. Additionally, he has collaborated with researchers at University of California San Diego on publications covering the evolving therapeutic landscape in lung cancer. Faisal was honored as a 2024 Rising Star in Equity Research by Business Insider, a recognition that underscores his exceptional contributions and the consistently high-quality analysis he delivers. His extensive background and expertise have also been highlighted during his time supporting the Emerging Oncology team. Faisal attended Brown University, where he earned an Sc.B. degree in biomedical engineering and conducted research on novel drug delivery technologies.